Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Tyler

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Frontiers in Immunology|October 16, 2024
Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapyColton Ladbury, Claire Hao, William Tyler Watkins, et al.
Scientific Reports|October 9, 2021
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancerStanley I Gutiontov, William Tyler Turchan, Liam F Spurr, et al.
JCO Precision Oncology|January 5, 2023
<i>STK11</i> Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung CancerRohan R Katipally, Liam F Spurr, Stanley I Gutiontov, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Frontiers in Immunology|October 16, 2024
Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapyColton Ladbury, Claire Hao, William Tyler Watkins, et al.
Scientific Reports|October 9, 2021
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancerStanley I Gutiontov, William Tyler Turchan, Liam F Spurr, et al.
JCO Precision Oncology|January 5, 2023
<i>STK11</i> Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung CancerRohan R Katipally, Liam F Spurr, Stanley I Gutiontov, et al.
Pageof 7